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Human monocytes are known to be multifunctional cells that combine a variety
offunctions, including phagocytosis, antigen processing and presentation to immune
cells, secretion ofa large number ofbioactive products with significant roles in the
immune and inflammatory reactions, and the ability to kill tumor cells and other
abnormal cells by a variety of mechanisms, including antibody-dependent cell-
mediated cytotoxicity (1-5). Tissue macrophages arebelieved to derive from circulat-
ing monocytes, although the two types of cells differ by a variety ofmorphological
and functional criteria (6-10). The role of macrophages is not always well under-
stood, since it combines potentially useful properties related to its ability to ingest
and process foreign and altered materials with the capacity to secrete large amounts
ofmediators having the potential to cause inflammatory changes and tissue damage
in general (I1-14). In atherosclerosis, substantial evidence has been gathered sug-
gesting that the "foam cells" seen in early atherosclerotic plaques are derived from
monocytes/macrophages (15-18). The formation and subendothelial accumulation
offoam cells are believed to represent a critical event in the onset of atheromatous
plaque formation (19).
Some interesting correlations can be drawn between the involvement of macro-
phages in the pathogenesis ofatherosclerosis and increasingevidence suggesting that
immunologic mechanisms may influence the development or evolution ofthispatho-
logic process. In the early 1970s, it was postulated that immune mechanisms in-
volving circulating immune complexes could contribute to the pathogenesis of ath-
erosclerosis (20). The evidence supporting this role ofimmune complexes was both
experimental (animals undergoing serum sickness and given alipid-rich diet devel-
oped accelerated atherosclerosis [21]) and clinical (patientswith IgA myelomas with
anti-lipoprotein activity had massive hyperlipemia and accelerated atherosclerosis
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[22]) . More recently, it was also shown that immune complexes (IC)' involving low
density lipoprotein (LDL) induce profound changes on cholesterol metabolism at
the cellular level (23) . Further support for the involvement of IC in the pathogenesis
of atherosclerosis has been recently obtained by Szondy et al. (24), who demonstrated
increased levels of IC and anti-LDL antibodies in patients with clinical manifesta-
tions of coronary heartdisease. The possibility that IC interactions with macrophages
may lead to their activation and, therefore, play a pathogenic role in the develop-
ment of atherosclerosis is extremely challenging.
Until recently, the mechanism proposed to explain how monocyte-derived mac-
rophages could be transformed into foam cells has focused upon the interaction be-
tween macrophages and modified LDL or lipoproteins of abnormal composition,
such as R-very low density lipoproteins (VLDL). Modified LDL can be taken up
in a nonregulated fashion via the scavenger receptor, resulting in the intracellular
accumulation of cholesteryl esters (CE) and in the formation of a foam cell. In con-
trast, it has been observed that cultured macrophages exposed to native LDL (N-
LDL) do not accumulate CE due to the stringent regulation of LDL receptors. How-
ever, it has been recently shown that in certain conditions, macrophages exposed
to native LDL may accumulate CE. In our laboratory, we have shown that human
macrophages stimulated with microbial or microbial-related products have an in-
creased uptake of N-LDL and accumulated CE (25). Tabas et al. (26) observed in-
creased uptake of N-LDL and concomitant CE accumulation in J774 cells, a mouse
macrophage-like tumor cell line. They postulated that this was due to the enhanced
metabolic activity ofthis tumorcell line (26). Klimov, et al . (27) had shownexcessive
CE accumulation in mouse peritoneal macrophages exposed to LDL immune com-
plexes compared with control cells. A common denominator for all these observa-
tions is the known ability of microbial products and immune complexes to activate
macrophages. Therefore, we decided to examine the effect of macrophage activation
on N-LDL metabolism. More specifically, we wanted to investigate the effect of LDL-
anti-LDL IC on N-LDL and cholesterol metabolism in human macrophages, and
determine whether this type of IC can induce the transformation of human macro-
phages into foam cells contributing to the development of atherosclerosis.
Materials and Methods
Isolation ofMonocytes.
￿
Monocytes were isolated from leukapheresis specimens by counter-
current centrifugal elutriation as previously described (28, 29). Briefly, leukapheresis speci-
mens were passed over standard Ficoll-Hypaque gradients to produce an unfractionated
mononuclear leukocyte suspension. These leukocyte cell preparations were then suspended
in elutriation medium (RPMI 1640 [Flow Laboratories, Inc., McLean, VA] with 2 g per
100 ml of clinical grade human albumin [Cutter Laboratories, Berkeley, CA] with a final
pH of 7.4) and entered with a Sarns cardiovascular pump (Highland Corp., Highland, IN)
into an elutriation chamber and rotor system (model JEG; Beckman Instruments, Inc., Palo
Alto, CA) at an initial medium flow rate of 5 ± 0.4 ml/min. The elutriation rotor speed was
maintained at 2,020 ± 10 rpm, and the centrifuge temperature was held at 18°C. All medium
used was documented to be endotoxin free (<0.1 ng/ml of endotoxin, by limulus assay) and
no antibiotics were added to any stage of the monocyte isolation procedure. The leukaphe-
1 Abbreviations used in this paper: CE, cholesteryl esters; d, density; HDL, high density lipoproteins;
IC, immune complexes; IMDM, Iscove's modified Dulbeccds medium; KHL, keyhole limpet hemocyanin;
LDL, low density lipoprotein; N, native; SFM, serum-free medium; VLDL, very low density lipoprotein.GRIFFITH ET AL.
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resis specimens used for the separation of monocytes as described above were obtained by
leukapheresis of normal volunteers for 2 h on a Celltrifuge II apparatus (Baxter-Travenol
Laboratories, Deerfield, IL). Donors with abnormalities on physical or laboratory examina-
tions were excluded as previously described (28).
Monocyte Identification Procedures.
￿
Thepurity ofthemonocyte preparations obtained by elutri-
ation was confirmed by morphology on Wright's-stained cytocentrifuge preparations, by
nonspecific esterase staining, andby the abilityto ingest latexparticlesas previously described
(30). Viability wasdetermined by trypan blue dyeexclusion. Theaveragepurity ofthe mono-
cytes used in this study by Wright's staining was 93%; by esterase staining, 92%; and by
latex ingestion, 93%. The average viability of the cells used was 99%.
Transformation ofMonocytes into Macrophages.
￿
Monocytes isolated as described above were
suspended in a specially formulated serum-free medium (SFM) to a final concentration of
10' cells/ml. The medium was prepared using Iscove's modified Dulbecco's medium (IMDM)
supplemented with human serum albumin (fatty acid free, 4 mg/ml), cholesterol (>90% pure,
20 Rg/ml), L-a-phosphatidylcholine (80 ug/ml), and human transferrin (98% pure, 1 wg/ml),
all from Sigma Chemical Co. (St. Louis, MO); human insulin (0.128 U/ml, Eli Lilly and
Co., Indianapolis, IN); and ferrous chloride (7 x 10 -" M, Fisher Scientific Co., Fairlawn,
NJ) as previously described (31).
1 ml of the above cell suspension was plated in each well of a 24-well Costar plate and
incubated at 37°C in a 5% C02 incubator for 2-3 h to allow the monocytes to adhere to
the plastic. Afterthis time, the medium was removed and replaced with medium containing
30% (vol/vol) ofwhole human serum (Whittaker M.A., Bioproducts, Walkersville, MD). The
cells were further incubated for 6-8 d, and the medium was changed every 3 d. The protein
content of the macrophages was on the average three times higher than that of monocytes,
thus, thepooled human serum used wasnottoxicforthecells. After maturation ofmonocytes
into macrophages, SFM containing no cholesterol was used to perform all the experiments.
Lipoprotein Isolation, Modification, and Labeling.
￿
Blood was collected in EDTA (1 mg/ml)
after 12 h of fasting. VLDL, LDL, and high density lipoproteins (HDL) were isolated from
plasma by sequential ultracentrifugation on an ultracentrifugerotor (L5-50, type 50; Beckman
Instruments, Inc.), as previously described(32). VLDL were isolated at plasma density(density
[d] <1.006 g/ml) at 50,000 rpm/min for 15 h. If chylomicrons were present, they were re-
moved by centrifuging the plasma at 26,000 g for 1 h before ultracentrifugation. LDL (d
> 1.019 < 1.063 g/ml) were isolated after appropriate adjustment of density with KBr, at 50,000
rpm/min for 22 h. HDL d> 1.063 < 1.21) were isolated after appropriate adjustment ofden-
sity with KBr, at 50,000 rpm/minfor24 h. LDL, HDL, andVLDL preparations were washed
by ultracentrifugation, dialyzed against a 0.15 M NaCl solution containing 1 mM of EDTA,
pH 7.4, and stored under nitrogen in the dark. They were passed through an Acrodisc filter
(0 .2-um pore size; Gelman Sciences, Inc., Ann Arbor, MI) in order to remove aggregates.
An aliquot of LDL was iodinated with
1'21'1 by the McFarlane procedure as modified by Bratz-
ler et al . (33). The labeling conditions were adjusted in order to obtain a specific activity
of 100-400 cpm/ng of protein. Radioactivity localized in thelipid moiety of the lipoproteins
was determined after a"Folch lipid extraction" (34) and constituted <4% of thetotal radioac-
tivity. Acetylation of LDL was performed using the protocol described by Basu et al. (35) .
Lipoprotein Accumulation and Degradation.
￿
Macrophages were incubated for 22 h with 250
ug of LDL containing immune complexes. After the incubation with IC, the medium was
removed, and the cells, after appropriate washing procedure, received 1 ml of fresh IMDM
medium containing 10 ug of "'I-labeled native LDL. In half of the culture wells, 250 wg of
unlabeled native LDL was appropriately added to correct for nonspecific degradation. In
some of the experiments, the IC were left for the duration of the experiment. The medium
removed after incubation with the lipoproteins was used to study LDL proteolytic degrada-
tion as described by Bierman et al. (36). The proteolytic degradation of "'I-labeled N-LDL
by human macrophages was measured by assaying the amount of
1251TCA-soluble (non-
iodide) material formed by the cells and excreted into the culture medium . Corrections were
made for the small amounts of "'l-labeled acid-soluble material that was found in parallel
incubations without cells.
The amount of '121'1-LDL bound and internalized by macrophages, i.e., cellular accumu-1044 LIPOPROTEIN IMMUNE COMPLEXES AND FOAM CELL FORMATION
lation, was determined by incubating the cells with '25I-LDI for 20 h at 37°C. After the in-
cubation, the medium was removed, and the cellswere washed two times with 1 ml PBS con-
taining 0.2% (wt/vol) BSA followed by two additional washes with PBS without albumin.
The cells were dissolved in 1 M NaOH, and an aliquot of the solubilized cells was taken
to determine the amount of '251-LDL radioactivity present in the cell pellet. Another aliquot
was used to determine the amount of cellular protein by the method of Lowry et al . (37).
To assay LDL binding, the above protocol was also followed, but the incubation as well
as the washing andharvesting procedures were performedat 4°C instead of37°C . The period
of incubation of LDL with the cells was 4 h. Saturation binding analysis of '2'I-N-LDL
bindingto LDL-IC-stimulatedmacrophagesand nonstimulated macrophagesincubatedwith
increasing concentrations of '251-N-LDL was performed. The data represent specific '25I-N-
LDL bound, determined from the difference in binding in the presence and absence of a
25-fold excess unlabeled N-LDL at the indicated concentrations, and is plotted against the
total '251-N-LDL concentration. The curves represent the best fit determined by unweighted
least-squares nonlinear regression analysis. Scatchard analysis was performed on the satura-
tion binding data as described (38, 39).
Competition Studies.
￿
In one series of experiments, '251-LDL-labeled immune complexes
(250 gg/ml) were added to macrophages incubated with SFM alone, SFM containing heat-
aggregated gamma globulin (10 mg/ml), SFM containing unlabeled N-LDL (250 wg/ml),
or SFM containing unlabeled Ac-LDL (250 wg/ml). The cultures were then incubated at
4°C for 4 h. After that period, the cultures were washed, and the cellular binding of '25I-
LDL-labeled IC was determined.
In another set of experiments, macrophages were incubated for 22 h, as described above,
with SFM or SFM containing LDL-IC . After the incubation, the medium was removed,
the cells were extensively washed, and '25I-N-LDL (10 wg/ml) was added to macrophages in-
cubated with SFM alone, SFM containing unlabeled N-LDL (250 ug/ml), or SFM containing
unlabeled Ac-LDL (250 ~ig/ml). The cells were incubated for4 hat 4°C, andafterthis period,
they were washed, and the cellular binding of 1251-LDL was determined.
Measurement of Total, Free, and Esterified Cholesterol Content in Macrophages.
￿
To perform these
experiments, 106 monocytes were plated in 24-well culture plates (Costar, Cambridge, MA)
and matured into macrophages as described above. Aftermaturation into macrophages, the
cellswere washed with PBS to remove wholehuman serum and incubated for 22 hwith SFM
alone or SFM containing immune complexes. Afterwards, the medium was removed, and
the cells were washed with PBS. To control and IC-stimulated dishes, SFM containing 100
4g/ml of native LDL was added. The cells were incubated for 20 h. In some of the experi-
ments, the medium after the 22-h incubation with immune complexes was not removed be-
fore the addition of LDL, and the cells were left in the presence of the IC throughout the
entire experiment (42 h). Afterwards, medium was removed, and the cells were extensively
washed with PBS. The macrophage monolayer was extracted with hexane/isopropanol (3 :2)
(vol/vol), as previously described (40). Free and total cholesterol were assayed on a gaschro-
matograph equipped with a hydrogen flame ionization detector. A glass column packed with
3% SP-2250 on 80/100 mesh Supelcoport was used for the chromatographic separation, and
its temperature was maintained at 250°C during the separation. N-2 was used as the gas
carrier.
For assayof totalcholesterol, the cellular extracts were evaporated to dryness and the res-
idue washydrolyzed by Ishikawa's method (41), as previously described (32). Cholesteryl ester
levels were obtained by subtracting free cholesterol from total cholesterol levels. R-Stigmasterol
was used as an internal standard.
Immunization andAntibody Isolation.
￿
For immunization, anarrow density cut (1 .030-1.050
g/ml) of human LDL was isolated. The rabbits received six immunizations over an 8-wk
period. For the primaryimmunization, 1 mg of LDL protein with an equal volume of CFA
was injected bilaterally, intramuscularly into all four quadrants. IFA was used for the second
immunization, and no adjuvant was used for subsequent immunizations. The plasma for
antibody isolation was obtained 7-10 d after the last immunization . Antibody was precipi-
tated from rabbit plasma using caprylic acid and 50% saturated ammonium sulfate (42).
Theprecipitate wasdissolvedin distilled water, dialyzed against 0.04M Tris-phosphate buffer,GRIFFITH ET AL.
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pH 8.4, and passed through aDEAE Sephacel column (Pharmacia Fine Chemicals, Piscataway,
NJ) . Absorbed proteins were eluted with a 0.04 M Tris-phosphate, pH 8.4, to 0.5 M Tris-
phosphate, pH 3.4, gradient . The IgG content was measured by absorbance at 280 nm . The
purity of the preparation was assessed by immunodiffusion and SDS-PAGE .
Preparation ofImmune Complexes .
￿
Insoluble immune complexes were prepared usingLDL
(1 mg/ml) and theIgG fraction ofa rabbit anti-LDL antiserum (1 mg/ml) . 1 ml ofantiserum
was incubated with varying amounts of LDL (5-1,000 gl) at 4°C overnight. Based on the
results of precipitin curves, the ratio ofAg/Ab giving the greatest amount of precipitate was
1 :10 (wt/wt) . The protein content of the insoluble IC was determined after washing three
timeswith PBSusing aprotein assay (Bio-Rad Laboratories, Richmond, CA)calibrated with
serial dilutions of apreparation of heavilyheat-aggregated IgG withknown amounts of IgG.
The sterility of the IC preparations was ensured by y irradiation .
Preparation of Heat-aggregated Gamma Globulin .
￿
Human gamma globulin (G4386 ; Sigma
Chemical Co .) at 20 mg/ml in PBS was heated at 63°C for 20 min . Protein was determined
by a Bio-Rad Laboratories assay and sterility was insured by y irradiation .
CRL-1703 Hybridoma.
￿
TheCRL 1703, known also as 9139, is a murine hybridoma ob-
tained from the American Type Culture Collection, Rockville, MD . It was made by Huet-
tinger et al . (43) against purified bovine LDL receptor and was determined to be of the IgG1
subclass . mAbs to bovine LDL receptors have been shown to crossreact with humanLDL
receptors (44) . The CRL-1703 were seeded at a density of 2 x 10 5 cells/ml in RPMI 1640
supplemented with 10% FCS and 4.5% glucose, as recommended . The hybridoma cultures
were grown to -106 cells/ml, whereupon the culture supernatants were harvested and used
as described in Results .
Oil-RedO Staining
￿
The neutral lipid inclusions inhuman monocyte-derived macrophages
were stained using oil-red O, as previously described (45) .
Statistics .
￿
Resultsarereported as mean f SEM. Thenonparametric Wilcoxon signed rank
sum test was used for the statistical comparison ofLDL degradation and accumulation, and
CE mass by stimulated and nonstimulated macrophages . Significance wasassumed forp values
<0.05 .
Results
Human macrophages stimulated for 22 h with LDL-IC (250 pg/ml) and exposed
afterwards to 1251-N-LDL for 20 h showed a four- and sixfold increase, respectively,
in the degradation and accumulation of 1251-N-LDL over the values observed in
nonstimulated cells (Fig . 1) (p < 0.05) . Experiments were performed either adding
1251-N-LDL to the cells after the removal of the LDL-IC as described above (Fig . 1)
or leaving the LDL-IC for 42 h (22 h before and 20 h after the addition of 1251-N-
LDL) . The stimulation of the uptake and degradation of 1251-N-LDL was further
FIGURE 1 .
￿
Receptor-mediated degrada-
tion andaccumulation of 1211-N-LDL (10
pg/ml) by human monocyte-derived mac-
rophages after 22 h ofstimulation with 250
pg/ml of LDL anti-LDL immune com-
plexes, (/), and 250 pg/ml anti-LDL
antibody (®), as compared with
nonstimulated control cells(0) . Values are
the means ± SEM for 13 experiments with
triplicate observations in each experiment .1046 LIPOPROTEIN IMMUNE COMPLEXES AND FOAM CELL FORMATION
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FIGURE 2 .
￿
Effect ofprogressively increas-
ing concentrations of LDL anti-LDI. im-
mune complexes on receptor-mediated ac-
cumulation (O) and degradation (") of
1251-N-LDL (10 wg/ml) by human macro-
phages stimulated for 22 h at the indicated
concentrations of l,131-anti-LDL immune
complexes. Values are a representative ex-
ample ofthree experiments with triplicate
observations in each experiment. All sub-
sequent experiments used LDL-anti-LDL
immune complexes at a concentration of
250 ug/ml .
enhanced when the LDL-IC were left throughout the experiment (data not shown).
The optimal LDL-IC concentration (250 wg/ml) and incubation time (22 h) were
determined through dose-response studies (Figs. 2 and 3). To exclude the possibility
that the heterologous antisera used to prepare the IC were responsible for the effect
observed on LDL uptake, we carried out control experiments incubating macrophages
with anti-LDL antisera; we did not observe any significant increase in the uptake
and degradation of 1251-N-LDL in these control experiments (p > 0.5) (Fig. 1) .
To determine the mechanism leading to increased uptake of LDL by LDL-IC-
stimulated macrophages, saturation binding isotherm studies were performed (Fig.
4, A and B) using progressive concentrations of )ZSI-N-LDL with or without a 25-
fold excess of N-LDL to determine nonspecific binding. The LDL-IC-stimulated
macrophages (Fig. 4 A) bound -10-fold more "'I-N-LDL than the nonstimulated
cells (Fig. 4 B). Scatchard plot analysis of the specific binding of 1251-N-LDL by
macrophages stimulated with LDL-IC (Fig. 5 A) indicates a slope of -9 .8 ± 0 .6
with an extrapolated x-intercept of 625 ng. Similar analysis of the data obtained
in nonstimulated macrophages reveals and approximate slope of -8 .5 ± 0.8 and
an extrapolated x-intercept of31 ng. These data suggests the presence of an increased
number of LDL receptors in macrophages stimulated with LDL-IC.
FIGURE 3.
￿
Temporal effect of LDL-anti-
LDL immune complexes upon receptor-
mediated degradation ( " , O) and ac-
cumulation (" , AL) of 1251-N-LDL by
human macrophages. Cells were stimu-
lated with LDL anti-LDL immune com-
plexes (closedsymbols) for the indicated time
periods compared to nonstimulated con-
trols (opensymbols). Values are the means
± SEM for three experiments with tripli-
cate observations in each experiment.-, 1poo
￿
FIGURE 4.
￿
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ment from a total of three experiments.
To rule out the possibility that the increased uptake of "'I-N-LDL observed in
our studies was mediated by the binding to Fc receptors of immune complexes formed
by the association of anti-LDL antibody released from the LDL-IC used for the
cell stimulation and 12'I-N-LDL added in the second phase of the experiment, the
following experiments were performed.
After appropriate incubation of macrophages with LDL-IC, as described above,
1 h before the 20-h incubation with 12'1-N-LDL, we added various concentrations
(250-500 ug/ml) of a F(ab')2 goat anti-rabbit IgG to nonstimulated and washed
LDL-IC-stimulated macrophages. With this step, we expected to crosslink any re-
sidual rabbit anti-LDL antibody remaining in the culture and prevent its binding
FIGURE 5.
￿
(A) Scatchard plot analysis of the specific
binding of 1251-N-LDL by macrophages stimulated
with LDL-anti-LDL immune complexes (") (slope,
-9.8 ± 0.6; x - intercept, 625 ng). (B) Scatchard
plot analysis of the specific binding of 1251-N-LDL
by nonstimulated macrophages (O), (slope, -8.5 ±
0.8; x - intercept, 31 ng). The data for scatchard
analysis was obtained from the specific 1251-N-LDL
binding in Fig. 4.1048 LIPOPROTEIN IMMUNE COMPLEXES AND FOAM CELL FORMATION
to '251-N-LDL. The concentrations of F(ab')2 goat anti-rabbit IgG were chosen after
determining, in preliminary experiments, that they effectively prevented insoluble
LDL-IC formation. No significant differences were found in the uptake of 1251-N-
LDL between LDL-IC-stimulated macrophages in the presence or absence of the
goat anti-rabbit antibody (data not shown). An alternate approach using the anti-
LDL receptor antibody obtained from the mouse hybridoma line CRL-1703 was
also pursued. Nonstimulated and washed LDL-IC-stimulated macrophages were
incubated with 1 ml, 500 pl, or 250 wl of the supernatant from the hybridoma cul-
ture containing anti-LDL receptor antibody (undiluted, twofold, and fourfold dilu-
tions). Since the hybridoma supernatants contained 10% FCS, parallel control cul-
tures of stimulated and nonstimulated macrophages were supplemented with 1 ml,
500 pl, and 250 41 of RPMI 1640 medium containing 10% FCS, to rule out possible
inhibition or stimulation of 1251-N-LDL accumulation by factors present in the FCS.
1 h later, '251-N-LDL (10 vg/ml) was added, and the cells were incubated at 4°C
for 4 h in a final volume of 1 ml. In the nonstimulated cells, irrespective of the dilu-
tion of the hybridoma supernatant, the specific accumulation of 1251-N-LDL was
inhibited by -70% (6.25 ng 1251-N-LDL accumulated per mg cell protein in con-
trol cultures vs. 1 .91 ng in anti-LDL receptor-treated cells). In the LDL-IC-stimulated
macrophages, the inhibition of specific '251-N-LDL accumulation decreased with
progressive dilutions of the hybridoma supernatant (49.7 ng'25I-N-LDL accumu-
lated per mg cell protein in control-stimulated cells vs. 2 .0 ng with undiluted hy-
bridoma supernatant, 8.4 ng with a 1 :2 dilution, and 11.4 ng 1251-N-LDL accumu-
lated with a 1 :4 dilution) . The marked inhibition of 1251-N-LDL accumulation by
the anti-LDL receptor antibody in the stimulated macrophages strongly supports
that the increased uptake of '25I-N-LDL is mediated by the LDL-receptor. Interest-
ingly, with maximum inhibitionin both the nonstimulated and LDL-IC-stimulated
cells, approximately the same amount of '25I-N-LDL accumulates (-2.0 ng/mg cell
protein). The residual accumulation seen in cells incubated with maximal concen-
trations of the monoclonal anti-LDL receptor antibody could be explained by the
fact that this antibody being raised against bovine LDL receptors and crossreactive
with human receptors may have a relatively low affinity to the human LDL receptor.
Alternatively, a certain proportion ofhuman LDL receptors may not crossreact with
the antiserum, although there is no concrete evidence for LDL receptor heteroge-
neity in humans. It needs to be noted that Beisiegel et al. (44) found that the human
LDL receptor in fibroblasts could be maximally inhibited (-80%) with an mAb
to bovine LDL receptor, a result strikingly similar to ours .
Another possible mechanism for the increased uptake of 1251-N-LDL observed in
our studies was a recognition of LDL-IC as modified LDL. If that occurred, the
increased uptake of "5I-N-LDL could be mediated by the uptake through the scav-
enger receptor of immune complexes formed by the association of anti-LDL anti-
body released from the LDL-IC used for cell stimulation and the '25I-N-LDL added
in the second phase ofthe experiment. To explore this possibility, we performed the
following competition experiments. Human macrophages were incubated at 4°C
for 4 h with 1251-LDL-labeled immune complexes (250 wg/ml) in presence of unla-
beled N-LDL (250 vg/ml), heat-aggregated gamma globulin (10 mg/ml), or unla-
beled Ac-LDL (250 wg/ml). Unlabeled N-LDL and HAGG inhibited the binding
of '25I-labeled LDL-IC by -22% and 70%, respectively. Acetylated LDL did not
inhibit 1251-labeled LDL-IC binding.GRIFFITH ET AL.
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To exclude the possibility that the "'I-N-LDL added to the stimulated macro-
phages was modified by the stimulated macrophages, competition studies in presence
of unlabeled N-LDL or unlabeled acetylated LDL were performed. The binding
of 1251-N-LDL to stimulated macrophages was not inhibited by acetylated LDL. In
contrast, it was markedly inhibited (84% inhibition) by unlabeled N-LDL (datanot
shown).
To determine whether the increased uptake of "'I-N-LDL in macrophages stimu-
lated with LDL-IC was accompanied by intracellular accumulation oflipids, we stained
the cells with oil-red and we measured by gas chromatography the total, free, and
esterified cholesterol content of the cells. Macrophages incubated with N-LDL after
LDL-IC stimulation for 22 h showed a greater number of oil-red-stained inclusions
than nonstimulated cells (Figs. 6, A and B). They also show significantly higher levels
of esterified cholesterol (ti13 times the values in nonstimulated cells: 185 ± 30 ug
CE/mg cell protein vs. 14 t 8 gg CE/mg cell protein) (p > 0.05) (Fig. 7). When
the LDL-IC were present throughout the entire assay (42 h), the cholesteryl ester
content increased to 16 times the levels observed in nonstimulated cells (232 ± 29
gg CE/mg cell protein vs. 14 ± 8 jig CE/mg cell protein) (Fig. 7).
Previous studies have shown a direct correlation between the size of IC and their
ability to be ingested and subsequently alter macrophage function (46-48). We wanted
to determine if the enhanced uptake of N-LDLwas specific for LDL-IC-stimulated
macrophages or ifit wasjust a general property of IC-stimulated macrophages. There-
fore, IC were prepared involving a variety of antigens such as IgG, transferrin, key-
hole limpet hemocyanin (KLH), and killed Candida albicans (both whole candida and
cytoplasmic protein extracts). All complexes were used at 250 ug/ml along with the
corresponding antibody control. IC prepared with C. albicans and KLH increased
the uptake and accumulation of LDL by 47% and 23%, respectively. Stimulation
of cells with IgG-IC did not alter LDL metabolism. In contrast, stimulation with
transferrin-IC depressed LDL metabolism (accumulation was 44% of the value ob-
tained in nonstimulated cells).
Since the effect on LDL metabolism seems to be considerably greater when the
cells were stimulated with LDL-IC than when other IC were used, we decided to
determine whether IC prepared with other lipoproteins would have a similar effect to
that observed with LDL-IC. Thus, IC were prepared with VLDL and HDL, and
the cells were stimulated as in the conditions previously described for LDL-IC . LDL-
IC-stimulated cells were used as controls. In VLDL-IC- and HDL-IC-stimulated cells,
the accumulation of "'I-N-LDL was approximately twofold over control values (Fig.
8). In contrast, in LDL-IC-stimulated cells, the accumulation of "'I-N-LDL was
-12-fold over the control values. When the studies were performed leaving the IC
throughout the length of the experiment, a more marked accumulation of "'I-N-
LDL was seen, especially in VLDL-IC-stimulated cells (sevenfold increase in 1251-
N-LDL uptake over nonstimulated cells) (Fig. 8).
Similarly to what happened in the experiments with LDL-IC, the cells stimulated
with VLDL-IC and HDL-IC for either 22 h or longer periods of time (42 h) showed
an increase in the total cholesterol mass (two times above control values), with CE
composing ti 43 % and 45 % of the total cholesterol mass, respectively (Figs. 9 and 10).
Finally, we wanted to determine whether the changes observed in LDL metabo-
lism stimulating macrophages with LDL-IC were also observed when monocytes
were submitted to similar stimulation. Fig. 11 illustrates that although monocytes1050 LIPOPROTEIN IMMUNE COMPLEXES AND FOAM CELL FORMATION
FIGURE 6 .
￿
Light microscopy photographs of oil-red-O-stained macrophages . (A) Nonstimulated
macrophages incubated for 20 h with 100 ug/ml of nativeLDL; (B) macrophages stimulated for
22 h with LDL-anti-LDL immune complexes and incubated for 20 h with 100 wg/ml of native
LDL . The degree of magnification (x60) was identical in both A and B.GRIFFITH ET AL .
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FIGURE 7 .
￿
Cholesterol mass (wg/mg cell pro-
tein) in macrophages stimulated with LDL-
anti-LDL immune complexes for 22 h (0)
vs . 42 h (0) as compared with nonstimulated
controls (0) . After a 22-h incubation with
LDL-anti-LDL immune complexes, the cul-
tures were washed to remove free immune
complexes, followed by a 20-h incubation with
100 ug/ml of native LDL . To a parallel set of
cultures, the native LDL was added for 20 h
at the end of the first 22 h of stimulation with-
out removing the LDL anti-LDL immune
complexes. The values expressed are the means
± SEM for eight different experiments with
triplicate observations in each experiment.
can be stimulated by LDL-IC to increase LDL uptake, the optimal stimulation by
LDL-IC occurred after 3 d in culture with 30% WHS . At that time, the cultured
monocytes have already acquired macrophage characteristics (49-51).
Discussion
The presence of large numbers of lipid-laden cells, also known as "foam cells" in
the early stages ofatheroma formation, has attracted the attention ofmany investi-
gators . Given the early appearance of these cells in the lesion, it is logical to believe
that some crucial steps in the pathogenesis ofatherosclerosis may be associated with
their formation . Most current evidence suggests that the large majority offoam cells
in the atherosclerotic lesion are derived from monocytes/macrophages (52-55). The
mechanisms leading to the transformation o£monocytes/macrophages into foam cells
have been the object of detailed studies . One of the best studied mechanisms in-
volves the recognition of modified lipoproteins by the scavenger receptor (51-54) .
Recently, however, it has become apparent that macrophage activation as a conse-
FIGURE 8 .
￿
Receptor-mediated accumula-
tion of "'I-N-LDL (10 ug/ml) in macro-
phages stimulated with LDL anti-LDL im-
mune complexes (0), VLDL antiVLDL
immune complexes (0), and HDL anti-
HDL immune complexes (19) for 22 h be-
fore the addition of radiolabelled LDL .
The values are expressed as a percentage
of the receptor-mediated 12-1I-N-LDL ac-
cumulation in nonstimulated cells (0)
(0.620 ng accumulated per mg cell pro-
tein) . The bars to the left represent the
levels of 1251-N-LDL accumulated in cul-
tures washed to remove free immune com-
plexes before the addition of radiolabeled
LDL . The bars on the right representlevels
of 1251-N-LDL accumulated in cultures
exposed to immune complexes throughout
the entire length of the experiment . The
values are the means _+ SEM for three ex-
periments with triplicate observations for
each experimental parameter.1052 LIPOPROTEIN IMMUNE COMPLEXES AND FOAM CELL FORMATION
FicuRE 9 .
￿
Cholesterol mass (wg/mg
cell protein) in macrophages incubated
for 20 h with 100 ug/ml native LDL
after stimulation for 22 h with LDL-
anti-LDL immune complexes (/),
VLDL-antiVLDL immune complexes
(®), and HDL-anti-HDL immune
complexes (®), compared with non-
stimulated controls (0) . The cultures
were washed at the end of the 22-h
stimulation period to remove free im-
mune complexes . The values expressed
are the means ± SEM for eight differ-
ent experiments with triplicate obser-
vations in each experiment .
quence of interactions with microbial or immunological products may also result
in lipid accumulation by monocytes/macrophages .
TheJ774 mouse macrophage-like tumor cell line shows excessive CE accumula-
tion when the cells are exposed to N-LDL . It has been postulated that the J774s,
due to their tumorigenic nature, may be either in an activated state or resistant to
the specific cellular regulatory mechanisms that prevent intracellular cholesterol ac-
cumulation (26) . Lopes-Virella et al . (25) have shown thathuman macrophages stimu-
lated by microbial or microbial-related substances when exposed to native LDL had
enhanced CE synthesis and accumulation . In contrast to the above studies, some
investigators have shown that activation of macrophages may lead to inhibition of
lipoprotein metabolism (56, 57) . Therefore, various stimuli may affect macrophage
lipoprotein metabolism quite differently. This is not surprising, since activation of
macrophages is a multistep process requiring an interplay of signals to achieve full
effector functions (13) and stimulation by various substances may activate different
pathways . Stevenson et al . (58) have recently shown that human monocyte/macro-
phages can be differentially activated to distinct secretory functions by a variety of
well-defined activation signals ; this differential functional capability stems from ac-
tivation signal- mediated gene transcription in some cases and post-transcriptional
regulation mechanisms in others (58, 59) . It is plausible, therefore, that different
activating signals may enhance or repress metabolic processes in different ways .
FIGURE 10 .
￿
Cholesterol mass (Rg/
mg cell protein) in macrophages in-
cubated with 100 gg/ml of native
LDL after stimulation for 42 h with
LDL-anti-LDL immune complexes
(/), VLDL-antiVLDL immune
complexes (®), and HDL-anti-
HDL immune complex (®) as
compared with nonstimulated con-
trols (EI) . The native LDL was
added to the cultures at the end of
the first 22 h stimulation ; the im-
mune complexes were not removed .
Values expressed are the means ±
SEM ofeight different experiments
with triplicate observations in each
experiment.r
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FIGURE 11.
￿
Receptor-mediated accumu-
lation of 1251-N-LDL (ug/ml) by nonstim-
ulated (0) and LDL-anti-LDL immune
complex stimulated cells (/) during
monocyte-to-macrophage maturation.
Thecells were studied either immediately
after isolation (monocytes) or after incu-
bation in 30% WHSfor 3, 5, and 7 d(mac-
rophages). Each bar represents the mean
± SEM of three different experiments
with triplicate observations in each ex-
periment.
In the present study, we assessed the effect of macrophage activation by immune
complexes on lipoprotein metabolism. Since in patients with clinical manifestations
of coronary heart disease, increased levels of circulating immune complexes con-
taining LDL have been reported (24, 60), we started by examining the effects of
macrophage activation with LDL-anti-LDL IC. Our results show that stimulation
of the cells with LDL-IC caused a marked increase in N-LDL uptake and degrada-
tion and led to intracellular CE accumulation and foam cell formation. Further-
more, we have shown that the enhanced uptake of LDL was due to an increase in
LDL receptor number in stimulated cells, and that the binding affinity was similar
in stimulated and nonstimulated cells.
Although the affinity of the LDL antibody is likely to be high since we obtained
the antisera from hyperimmune rabbits, we could not rule out the possibility that
during the washing procedure, IC bound to the cells could become free, dissociate,
and the released antibody could form a new complex with the "'I-N-LDL added
to the system. If that happened, the increased uptake of 1251-N-LDL seen after stim-
ulation of the macrophages with LDL-IC could be due to the uptake of the new
complexes either through the Fc receptor or through the scavenger receptor. The
latter possibility would occur if the LDL-IC were recognized as modified LDL and
thus taken up by the scavenger receptor. This hypothesis was excluded, since we
have shown that acetylated LDL did not inhibit the binding of "5I-labeled LDL-
IC to the macrophages. The likelihood of increased N-LDL uptake through Fc
receptors is also minimal since goat anti-rabbit [F(ab')2] IgG did not inhibit "5I-
N-LDL uptake in stimulated cells. Furthermore, our experiments showing a marked
inhibition of 1251-N-LDL uptake in cells preincubated with an anti-LDL receptor
antibody favors the hypothesis that an increase in LDL receptor number occurred
in LDL-IC-stimulated macrophages.
Finally, the unlikely possibility that 1251-LDL was modified by products released
by the stimulated macrophages and taken up by the scavenger receptor was excluded
since acetylated LDL did not inhibit the uptake of 1251-N-LDL in stimulated cells.
A major question of this study was whether the ability of LDL-IC to stimulate
macrophages and promote increased uptake and degradation of 1251-N-LDL, along
with increased CE accumulation, is specific for a certain type of IC or a general
property of IC-stimulated macrophages. We studied the effects of several immune1054 LIPOPROTEIN IMMUNE COMPLEXES AND FOAM CELL FORMATION
complexes varying in antigen composition and size. Some of the IC were able to
stimulate, although to a lesser degree, the uptake of native LDL by macrophages,
but our data indicate that lipoprotein IC are more efficient and have the greatest
capacity to increase uptake of N-LDL and CE accumulation. The ability to pro-
mote '25I-N-LDL accumulation was enhanced if the ICs were present continuously
throughout the culture. This was evident both in LDL-IC and in VLDL-IC-stimulated
macrophages. Our results suggest that the type of antigen contained within the IC
plays a role in the ICs ability to perturb intracellular regulatory mechanisms oflipo-
protein metabolism. Therefore, the alteration of lipoprotein metabolism must be
a consequence of mechanisms other than the general activation of macrophages by
the interaction of IC with Fc receptors. Recently, Tabas and Boykow (61) have
postulated the presence of a short-lived intracellular protein that inhibits ACAT
mediated cholesterol esterification in mouse peritoneal macrophages and that may
be missing or inactivated in the J774 macrophages. It is possible that a similar
phenomenon may occur in activated human macrophages such that stimulation or
inhibition of ACATmediated cholesterol esterification may depend on the type of
antigen contained in the IC . Ifthe IC was to enhance ACAT activity, the intracellular-
free cholesterol levels would decrease and lead to increased LDL receptor expres-
sion . Such alterations in macrophage physiology may contribute to CE accumula-
tion and concomitant foam cell formation.
Two possible mechanisms, not mutually exclusive, may contribute to the increased
intracellular CE accumulation. One, as mentioned above, involves the increased LDL
uptake due to the enhancement in LDL receptor expression induced by LDL-IC
cell activation. The other involves the uptake by Fc receptors of the LDL contained
in the IC used to stimulate the macrophages with resulting intracellular accumula-
tion. The later mechanism has been described by Klimov et al. (27), who demon-
strated that mouse peritoneal macrophages stimulated with LDL-IC had a CE con-
tent 60 times the levels obtained in nonstimulated cells. The magnitude of CE
accumulation in our studies is considerably less as we found only a 10-15-fold in-
crease in the CE accumulation in stimulated cells vs. nonstimulated cells. This may
be due to the length of incubation with the LDL-IC, as the mouse peritonealmacro-
phages were incubated for 72 h vs. our incubation times of 22-42 h or to differences
between the metabolic behavior of human and murine macrophages.
Our studies show conclusively that the formation offoam cells is an active process,
associated with several signficant functional changes. Given the wide range of ef-
fector functions of macrophages, it is likely that the activation caused by LDL-anti-
LDL-IC will be reflected not only in lipid metabolism, but also in other functions,
Among the general functions of macrophages whose activation may be significant
in the pathogenesis of atherosclerosis are the release of proteases and collagenase,
growth factors, and smooth muscle cell mitogens, all of which are particularly rele-
vant. Preliminary data obtained in our laboratory suggests that macrophage-derived
growth factor is released in increased amounts by macrophages incubated with LDL-
anti-LDL-IC (data not shown).
The significance of our findings hinges heavily on the natural occurrence ofanti-
LDL antibodies. Such antibodies have been described in patients with atheroscle-
rosis (24, 60) and LDL isolated from patients with CHD has been shown to be im-
munologically different from N-LDL. It is also known that the respiratory burstGRIFFITH ET AL.
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of macrophages is associated with the release of reactive oxygen intermediates and
other products (62-64) which have the potential of modifying LDL (65, 66). Such
modifications, interestingly enough, are associated with increased immunogenicity
and production of autoantibodies (67-69). Therefore, it could be postulated that
macrophage activation by infectious or otherstimuli could lead to the initial modifica-
tion of LDL, and subsequently to the formation of antibodies to modified LDL,
soluble IC involving either modified or native LDL could be formed (the antibodies
to modified LDL would likely be crossreactive with native LDL). The formation
of LDL-IC would promote foam cell formation and perpetuate the cycle of macro-
phage activation LDL modification, playing a significant role in the development
and perpetuation of atherosclerotic lesions.
Summary
Human macrophages play a key role in atherogenesis and are believed to be the
progenitors of the cholesteryl ester (CE)-laden foam cellspresent in early atherosclerotic
lesions. Several mechanisms by which macrophages accumulate CE have been re-
cently described. One involves a perturbation in LDL metabolism subsequent to
macrophage activation. Thus, we decided to study the effect of macrophage activa-
tion by immune complexes on N-LDL metabolism. Initially, LDL-containing im-
mune complexes (LDL-IC) were chosen, since increased plasma levels of these IC
have been reported in patients with coronary heart disease. Human macrophages
stimulated for 22 h with LDL-IC (250 wg/ml) and incubated afterwards for 20 h
with 10 ug/m1 1251-N-LDL showed a six- and fourfold increase in the accumulation
and degradation, respectively, of 1251-N-LDL over the values observed in nonstimu-
lated cells. Scatchard analysis of 1251-N-LDL-specific binding suggests an increase
(20-fold) in the number of LDL receptors in macrophages stimulated with LDL-IC.
We studied other immune complexes varying in size and antigen composition. Some
of the IC were able to stimulate, although to a lesser degree, the uptake of N-LDL
by macrophages. Lipoprotein IC are more efficient and have the greatest capacity
to increase N-LDL uptake and CE accumulation. We conclude that human macro-
phage activation by LDL-IC leads to an increase in LDL receptor activity and pro-
motes in vitro foam cell formation.
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